Abiopharma

🔍 Ballard John Scott (Director)

Company: HOME BANCORP, INC. (HBCP)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Acquired 100 shares of Common Stock (Direct)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,850.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Includes the grant of 100 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on June 12, 2027 and that may be settled only in shares of the Issuer's common stock.
• F2: Includes the grant of 500 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2027 and that may be settled only in shares of the Issuer's common stock.
• F3: Includes the grant of 600 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023 and that may be settled only in shares of the Issuer's common stock.
• F4: Includes the grant of 600 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024 and that may be settled only in shares of the Issuer's common stock.
• F5: Includes the grant of 600 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025 and that may be settled only in shares of the Issuer's common stock.
• F6: Includes the grant of 700 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2026 and that may be settled only in shares of the Issuer's common stock.